Retroviral vectors: from cancer viruses to therapeutic tools

about

Virotherapy: cancer gene therapy at last?Characterization of retroviral infectivity and superinfection resistance during retrovirus-mediated transduction of mammalian cells

P2860

Q28066228-ED139ABC-DC84-4FA4-821E-87676961B2F3 Q33895829-3A642A9A-D4D7-41BF-B44E-6C1E4D3E501A

P2860

Retroviral vectors: from cancer viruses to therapeutic tools

Item

http://www.wikidata.org/entity/Q38280077

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Retroviral vectors: from cancer viruses to therapeutic tools

@en

type

Item

label

Retroviral vectors: from cancer viruses to therapeutic tools

@en

prefLabel

Retroviral vectors: from cancer viruses to therapeutic tools

@en

P1476

Retroviral vectors: from cancer viruses to therapeutic tools

@en

P2093

A Dusty Miller

http://www.w3.org/2001/XMLSchema#string

P2860

A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction

Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1

Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses

Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation

Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters

A family of retroviruses that utilize related phosphate transporters for cell entry

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

P304

989-994

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2014.2542

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

A. Dusty Miller, Arthur G. Miller

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25458252

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

4270132

http://www.w3.org/2001/XMLSchema#string

Retroviral vectors: from cancer viruses to therapeutic tools

about

P2860

P2860

Retroviral vectors: from cancer viruses to therapeutic tools

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932